Lupin the domestic pharma major has launched its generic version of Moxifloxacin Hydrochloride Ophthalmic solution in the US market which is used in treating bacterial...
EquityPanditβs Outlook for Lupin for the week Β (JuneΒ 05, 2017 β JuneΒ 09, 2017) : LUPIN: Lupin closed the week on positive note gaining around...
Lupin, the pharma major, has received six US FDA Form 483 observations for its Indore plant. The regulator has said that the observations included no...
Lupin, the drug firm has received the approval from India’s Central Drugs Standard Control Organisation (CDSCO) for Bepotastine tablets that are used in treating patients...